Traumatic Brain Injury ResearchPsychosomatic Disorders and Their TreatmentsDementia and Cognitive Impairment Research

Sarah J. Schneider, John-Christopher A Finley, Alex R. Daros, M. Holcomb, Robert M. Roth, Laszlo A. Erdodi

2026.2.21Psychological Injury & Law

DOI: 10.1007/s12207-026-09559-w

Abstract

This study was designed to examine the potential of the clinical scales of the V-5 (a visual analog scale) to serve as embedded symptom validity tests (SVTs) in a mixed clinical sample. Archival data were collected from a consecutive case sequence of 100 adult outpatients physician-referred for neuropsychological evaluation. The V-5 was administered twice: at the beginning (Time 1) and the end of the battery (Time 2). The classification accuracy of the V-5 as an SVT was calculated against psychometrically operationalized non-credible symptom report and invalid performance on cognitive testing. Using SVTs as criterion measures, ≥70 on the Depression scale had .41-.67 sensitivity at .89-.94 specificity. Different cutoffs were needed on the Anxiety scale at Time 1 (≥80; .44-.63 sensitivity at .88-.90 specificity) and Time 2 (≥65; .44-.57 sensitivity at .88-.93 specificity). A score ≥60 on the Pain scale had low sensitivity (.20-.41) but high specificity (.87-.94). Aggregating the number of failures on the V-5 within and across administrations consolidated specificity (.90-.99) at a proportional cost to sensitivity (.22-.57), correctly classifying between 84% and 93% of the overall sample. A cutoff of ≥170 on the sum of the scores on all three scales (Depression, Anxiety, and Pain; DAP) at Time 1 produced a good combination of sensitivity (.50-.75) and specificity (.92-.95), correctly classifying 87.0-93.2% of the sample. A DAP cutoff of ≥160 had comparable specificity (.91-.94), but lower sensitivity (.33-.43) and overall correct classification (83.5-89.2%) at Time 2. Results are consistent with previous research on the V-5 as an embedded SVT in student samples. Considering its low cost, the V-5 provides a practical addition to the existing list of SVTs. The fact that validity cutoffs leave little room for credible emotional distress (the invalid before clinically elevated paradox) on the V-5 introduces a psychometric conundrum that will need to be addressed in future research.

Citation format

SCHNEIDER, Sarah J., et al. Visual analog scales of depression, anxiety, and pain as embedded symptom validity indicators in a mixed clinical sample. Psychological Injury & Law, 2026, 19(1).